Evidence review
GLP-1s and Pregnancy: What to Know if You're Planning — or if You Conceive While on One
GLP-1s aren't used in pregnancy. The animal safety signal, what large human studies found, and a calm plan if you conceive while on Ozempic or Zepbound.
Elena Voss is a mother writing for mothers, not a treating clinician. The evidence in this piece was checked against its primary sources by Grant Okonkwo, a former pharmaceutical-industry analyst — Elena and Grant hold no medical license, and this is background reading, not medical advice.
On this page
The short version
Two questions bring most mothers here, and they deserve different answers. If you are planning a pregnancy, the guidance is clear: GLP-1 medications are not used in pregnancy, so you stop before you conceive, on a planned washout1. If you have already conceived while on one — which happens, because these drugs can quietly restore fertility2 — the honest answer is more reassuring than the label alone suggests. The concern comes from animal studies, where GLP-1 exposure in pregnancy has been linked to reduced fetal growth and skeletal, visceral, and embryonic harm2. But the human data, now pooled across tens of thousands of exposed pregnancies, have not shown a significant increase in major birth defects34. The right move if you see a positive test is not panic — it is to stop the drug and call your OB promptly1.
This is educational only, not medical advice.
Why GLP-1s are not used in pregnancy
The caution starts in the lab. Animal reproductive studies of GLP-1 receptor agonists have shown adverse offspring outcomes — decreased fetal growth, skeletal and visceral anomalies, and embryonic death — which is why the labels advise against use in pregnancy and why prescribers plan a washout before conception2. Layered on top is a simple absence: pregnancy is an exclusion criterion in the trials, so there is no body of prospective human safety data to lean on2. When a drug shows a signal in animals and has thin human evidence, the conservative default in obstetrics is not to use it — and that is the position the FDA labels take1.
What the human data actually show
This is the part that should lower the temperature for anyone facing an unplanned exposure. Because inadvertent first-trimester exposure has become more common, researchers have now pooled the real-world evidence5:
- A 2026 systematic review and meta-analysis of periconceptional GLP-1 exposure — six studies, roughly 286,000 women, about 43,000 exposed — found no significant difference in the risk of major congenital malformations between exposed and unexposed pregnancies3.
- A separate 2026 meta-analysis of seven cohort studies covering more than 40,000 exposed pregnancies likewise found that exposure was not associated with a statistically significant increase in congenital malformations, nor in stillbirth, miscarriage, small-for-gestational-age, or preterm birth4.
The caveats belong here too, honestly. That second analysis flagged a possible signal for urinary-tract malformations that rested on unadjusted data, and the broader safety review stresses that the overall evidence base is still sparse and not a green light to continue a GLP-1 into pregnancy45. So the fair summary: the accumulated human data are genuinely reassuring about an accidental early exposure, while still supporting the standard advice to stop the drug once pregnancy is known.
If you conceive while on a GLP-1: a calm plan
- Stop the medication. The guidance is to discontinue a GLP-1 once pregnancy is recognized1. Do not take another dose while you sort out next steps.
- Call your OB or prescriber promptly. Tell them exactly which product and dose you were on and when your last dose was. This is routine for them, and the reassuring human data are worth hearing from your own clinician34.
- Don't spiral. An early, inadvertent exposure is not known to meaningfully raise the risk of major birth defects based on the pooled human evidence34. Standard early-pregnancy care — prenatal vitamins with folate, your normal first prenatal visit, and any monitoring your OB recommends — is the path forward.
- Ask about the weight-management plan for pregnancy. The goal shifts from weight loss to healthy gestational weight gain; your OB will help you reset expectations for the months ahead.
Planning ahead is still the better path
None of the above changes the ideal: if a pregnancy is on your horizon, plan the stop rather than discover it. That means contraception while you are still on the drug, a deliberate washout — about two months for semaglutide given its slow clearance1 — and only then trying to conceive. Our guide to trying to conceive on a GLP-1 lays out that sequence, and if you have PCOS, Ozempic for PCOS explains why fertility can return faster than you expect. For the postpartum side — including when it is reasonable to restart — see GLP-1s and breastfeeding.
Choosing a provider that handles this well
The tell of a serious program is that it raises pregnancy intentions before prescribing, plans contraception, and knows the washout timing cold — not one that treats reproduction as an afterthought. That reproductive-aware oversight is part of what our Metabolic-Fit Score methodology rewards, and why clinician-led options such as CoreAge Rx rank near the top of our best GLP-1 providers for women; some links here earn us a referral fee. This article is educational only and not medical advice — pregnancy decisions belong with an obstetric clinician who knows your history.
Frequently asked questions
Is it dangerous if I got pregnant while taking Ozempic or Zepbound?
The reassuring news is that pooled human data — including two 2026 meta-analyses covering tens of thousands of exposed pregnancies — have not shown a significant increase in major birth defects after early GLP-1 exposure. The concern originates in animal studies. The standard advice is to stop the drug as soon as you know you're pregnant and call your OB promptly, not to panic.
What should I do if I conceive while on a GLP-1?
Stop the medication, then contact your OB or prescriber promptly and tell them which product and dose you were on and when your last dose was. Continue standard early-pregnancy care — prenatal folate and your normal prenatal visits. The goal shifts from weight loss to healthy gestational weight gain.
Can I stay on a GLP-1 during pregnancy if it's helping my weight?
No. GLP-1 medications are not used in pregnancy — animal studies showed fetal harm and human safety data remain sparse, so the labels advise discontinuing when pregnancy is recognized. Weight management in pregnancy is handled differently, with your obstetric clinician.
References
- U.S. Food and Drug Administration (2024). Wegovy (semaglutide) injection — Prescribing Information (Use in Specific Populations: Pregnancy; discontinue when pregnancy is recognized). DailyMed / FDA. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee06186f-2aa3-4990-a760-757579d8f77b
- Drummond RF, Seif KE, Reece EA (2025). Glucagon-like peptide-1 receptor agonist use in pregnancy: a review. American Journal of Obstetrics and Gynecology. https://pubmed.ncbi.nlm.nih.gov/39181497/
- Liu X, Xiong B, Yang R, Wang H, Liu Y (2026). Periconceptional use of GLP-1 receptor agonists and the risk of major congenital malformations: a systematic review and meta-analysis. Endocrine Connections. https://pubmed.ncbi.nlm.nih.gov/42447044/
- Uysal N, Horoz E, Gungor M, et al. (2026). Pregnancy outcomes following maternal GLP-1 receptor agonist exposure: a systematic review and meta-analysis. Scientific Reports. https://pubmed.ncbi.nlm.nih.gov/42420519/
- Ozbek L, Shah E, Al-Shiab R, et al. (2026). Safety of GLP-1 and Dual GLP-1/GIP Receptor Agonists in Preconception, Pregnancy, and Lactation: A Systematic Review of Maternal, Fetal, and Neonatal Outcomes. Diabetes, Obesity and Metabolism. https://pubmed.ncbi.nlm.nih.gov/41885132/
Background reading, not medical advice. MomMetabolic summarizes published research and FDA labeling for mothers weighing GLP-1 care. It cannot diagnose you, cannot account for your history or hormones, and is no substitute for a licensed clinician who can. Decisions to begin, adjust, pause, or stop any medication belong with your own prescriber.
Continue reading
Ozempic for PCOS: Does It Actually Work — and Is It Even Approved?
Ozempic isn't approved for PCOS — every use is off-label. What the trials really show for weight, cycles, and fertility, and how it compares to metformin.
ReadTrying to Conceive on a GLP-1: Washout Timing and the Fertility Evidence
GLP-1s aren't used in pregnancy, so conception means a planned washout. The stop-before-pregnancy window, the ovulation science, and the honest fertility data.
ReadGLP-1 and Breastfeeding: What the Label Actually Says
The Wegovy and Zepbound labels don't say safe or unsafe for nursing — they advise against use. What that means, and why it's really about timing.
Read